CLINICAL IMMUNOLOGY
Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients
Submission date: 2016-08-14
Acceptance date: 2016-09-02
Publication date: 2017-10-30
Cent Eur J Immunol 2017;42(3):281-286
KEYWORDS
ABSTRACT
Introduction: Adenosine and deoxyadenosine metabolism is influenced by adenosine deaminase (ADA) enzyme. ADA increases in different diseases and is considered as one of the markers for cell-mediated immunity. Pregnancy is associated with depressed cell-mediated immunity. The level of ADA expression, which seems to play a key role in maintaining pregnancy, is influenced by adenosine deaminase G22A gene polymorphism. We aimed in our study to evaluate the association of ADA G22A gene polymorphism with recurrent spontaneous abortion (RSA) in Egyptian women.
Material and methods: Adenosine deaminase G22A gene polymorphism was genotyped in 40 patients (age range 22-39 years) with a history of RSA, selected from those attending the Gynaecology and Obstetrics Clinic of Beni-Suef University Hospital, and 20 age-matched healthy women as a control group, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
Results: In our study, no statistically significant difference was found between RSA patients and control group as regards ADA G22A genotypes (p = 0.653) and alleles (p = 0.697). A comparison of the frequencies of ADA alleles in RSA patients as regards the below-35-years-old age group revealed that ADA 2(A) allele was associated with a low risk for RSA in patients aged 35 years old or younger (p = 0.008).
Conclusions: In conclusion, our study revealed an age-dependent protective value of ADA 2(A) allele in recurrent spontaneous abortions among the Egyptian population.
Material and methods: Adenosine deaminase G22A gene polymorphism was genotyped in 40 patients (age range 22-39 years) with a history of RSA, selected from those attending the Gynaecology and Obstetrics Clinic of Beni-Suef University Hospital, and 20 age-matched healthy women as a control group, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
Results: In our study, no statistically significant difference was found between RSA patients and control group as regards ADA G22A genotypes (p = 0.653) and alleles (p = 0.697). A comparison of the frequencies of ADA alleles in RSA patients as regards the below-35-years-old age group revealed that ADA 2(A) allele was associated with a low risk for RSA in patients aged 35 years old or younger (p = 0.008).
Conclusions: In conclusion, our study revealed an age-dependent protective value of ADA 2(A) allele in recurrent spontaneous abortions among the Egyptian population.
REFERENCES (27)
1.
Schorge JO, Schaffer JI, Halvorson LM, et al. (2008): First-Trimester Abortion. Williams Gynecology. McGraw-Hill Medical.
2.
Sedgh G, Singh S, Shah IH, et al. (2012): Induced abortion: Incidence and trends worldwide from 1995 to 2008. Lancet 379: 625-632.
3.
Jahaninejad T, Ghasemi N, Kalantar SM, et al. (2013): StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion. J Assist Reprod Genet 30: 437-440.
4.
Dong RP, Kameoka J, Hegen M, et al (1996): Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 156: 1349-1355.
5.
Franco R, Pacheco R, Gatell JM, et al. (2007): Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell dendritic cell contacts and in alterations of the immune function. Crit Rev Immunol 27: 495-509.
6.
Takhshid M A, Zahediannejad Z, Aboualizadeh F, et al. (2015): G22A Polymorphism of Adenosine Deaminase and its Association with Biochemical Characteristics of Gestational Diabetes Mellitus in an Iranian Population. Iran J Med Sci 40: 170-174.
7.
Pospisilova H, Frebort I (2007): aminohydrolases acting on adenine, adenosine and their derivatives. Biomed Pap Med 3: 151.
8.
Jadhav A, Jain A (2013): Adenosine deaminase activity in normal pregnancy and pregnancy associated disorders. Arch Physiol Biochem 119: 88-91.
9.
Mishra OP, Gupta BL, Ali Z, et al. (1994): Adenosine deaminase activity in typhoid fever. Indian Pediatr 31: 1379-1384.
10.
Santosh UP, Renukananda GS, Abhilash S (2016): Role of adenosine deaminase in common chronic ENT infections.
12.
Salehabadi M, Farimani M, Tavilani H, et al. (2016): Association of G22A and A4223C ADA1 gene polymorphisms and ADA activity with PCOS. Syst Biol Reprod Med 62: 213-222.
13.
Yoneyama Y, Sawa R, Suzuki S, et al. (2002): Regulation of plasma adenosine levels in normal pregnancy. GynecolObstet Invest 53: 71-74.
14.
Lee SJ, Hwang HS, Kim BN, et al. (2007): Changes in serum adenosine deaminase activity during normal pregnancy. J Korean Med Sci 22: 718-721.
15.
Melzig M, Paun I (1992): Modulation of adenosine deaminase activity of endothelial cells by steroids. Pharmazie 47: 394.
16.
Yoneyama Y, Suzuki S, Sawa R, et al. (2003): Serum adenosine deaminase activity and its isoenzyme pattern in women with normal pregnancies. Arch Gynecol Obstet 267: 205-207.
17.
Aiuti A, Cattaneo F, Galimberti S, et al. (2009): Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360: 447-458.
18.
Riksen NP, Franke B, van den Broek P, et al. (2008): The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo. Pharmacogenet Genomics 18: 843-846.
19.
World Medical Association (2008): Declaration of Helsinki: ethical principles for medical research involving human subjects. The 59th WMA General Assembly, Seoul, South Korea.
20.
Nunes DP, Spegiorin LC, Mattos CC, et al. (2011): The ADA 2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association. Clinics (Sao Paulo) 66: 1929-1933.
21.
Dawson B, Trapp RG (2001): Basic and clinical biostatistics. 3rd ed. McGraw-Hill, New York.
22.
Nicotra M, Bottini N, La Torre M, et al. (2007): Repeated spontaneous abortion. Cooperative effects of ADA and ACP1 genetic polymorphisms. Am J ReprodImmunol 58: 1-10.
23.
Hirschhorn R, Yang D, Israni A (1994): An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme). Ann Hum Genet 58: 1-9.
24.
Napolioni V, Lucarini N (2010): Gender-specific association of ADA genetic polymorphism with human longevity. Biogerontology 11: 457-462.
25.
Chen JF, Eltzschig HK, Fredholm BB (2013): Adenosine receptors as drug targets – what are the challenges? Nat Rev Drug Discov 12: 265-286.
26.
Bahadir G, Doventa Y, Turkal R, et al. (2011): Serum adenosine deaminase and its isoenzyme activities in pregnancy. Turk Ger Gynecol Assoc 12: 209-213.
27.
Fattahi A, Khodadadi I, Amiri I, et al. (2015): The Role of G22 A Adenosine Deaminase 1 Gene Polymorphism and the Activities of ADA Isoenzymes in Fertile and Infertile Men. Urology 86: 730-734.
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
